Nigel Rawson

Contributor

Nigel Rawson is an independent researcher in Saskatoon and an affiliate scholar with the Canadian Health Policy Institute.

1 Contribution
by Nigel Rawson John Adams

Pharmacare reform pits affordability against access to novel drugs

For many Canadians, important pharmaceuticals are too expensive. But initiatives by the Trudeau government and a federal regulator to combat this problem won't help Canadians access new, life-saving, but costly medicines. Just the opposite.

1 of 1